Outcome of Board Meeting

September 28, 2026 To To The Manager, Listing Department The General Manager, Listing Department National Stock Exchange of India Ltd. BSE Limited Plot no. C/1 G Block, Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (East), Dalal Street, Mumbai- 400 051 Mumbai- 400 001 Symbol: BLISSGVS Scrip Code: 506197 Dear Sir/Madam, Subject: Outcome of Board Meeting pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"). Ref: Disclosure under Regulations 30 of the SEBI Listing Obligations. Pursuant to Regulations 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. September 28, 2026, has, inter alia, considered and approved/noted the following matters in relation to the consummation of the transaction contemplated in the share purchase agreement dated May 23, 2026 (“SPA”) entered into amongst Anupam Rasayan India Limited (“Purchaser”), the Sellers (as defined in the SPA), including Mr. S. N. Kamath as Seller 1 (as defined in the SPA), read with the Deed of Adherence dated July 17, 2026 executed between Mates Visa Consultancy Private Limited (“PAC”) and the Purchaser whereby the Purchaser had assigned its rights under the SPA to PAC (collectively, “Transaction Documents”): 1) Change in Control and Promoter Status: The PAC has completed the acquisition of 5,09,84,595 equity shares of Bliss GVS Pharma Limited (“Company”), representing 47.95% of the equity share capital of the Company as on date of the meeting, pursuant to the consummation of the transaction contemplated in the SPA on September 28, 2026. Following the aforesaid acquisition, and together with 1669 equity shares of the Company acquired by the Purchaser under the Open Offer, the Purchaser and the PAC collectively hold an aggregate of 5,09,86,264 equity shares of the Company, representing 47.95% of the equity share capital of the Company. Accordingly, with effect from September 28, 2026, Anupam Rasayan India Limited, along with Mates Visa Consultancy Private Limited, being the Purchaser and PAC, respectively, have acquired control of the Company pursuant to the completion of the Open Offer (as defined in the SPA) and the consummation of the transaction contemplated under the SPA and therefore have become the ‘Promoters’ of the Company in accordance with the applicable provisions of the SEBI Listing Regulations and the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. 2) Appointment of Directors: a) Appointment of Mr. Hetul Krishnakant Mehta [DIN:01650314] as an Additional Director of the Company in the capacity of a Non-Executive Non-Independent Director with effect from September 28, 2026. b) Appointment of Mr. Amar Dilip Shah [DIN: 00214357] as an Additional Director of the Company in the capacity of a Non-Executive Non-Independent Director with effect from September 28, 2026. c) Appointment of Mr. Pramod Badrinarayan Kasat [DIN: 00819790] as an Additional Director of the Company in the capacity of a Non-Executive Non-Independent Director with effect from September 28, 2026. The brief profile and other requisite details pertaining to the aforesaid appointment are enclosed as “Annexure – 1”, “Annexure – 2” and “Annexure – 3”, respectively. 3) Resignation of Mr. Narsimha Shibroor Kamath (DIN: 00140593) from the position of Managing Director of the Company and other positions: The Board has noted and taken on record the resignation of Mr. Narsimha Shibroor Kamath (“Mr. Kamath”) from the position of Managing Director of the Company with effect from September 28, 2026. The resignation letter received from Mr. Kamath is enclosed herewith. The requisite details as required under Regulation 30 of the SEBI Listing Regulations read with Schedule III thereof SEBI Master Circular No. HO/49/14/14(7)2025-CFD- POD2/I/3762 /2026 dated January 30, 2026 attached as “Annexure – 4”. 4) Approval of Postal Ballot Notice: Approved the draft Postal Ballot Notice seeking approval of the Members of the Company for the appointment of Mr. Hetul Krishnakant Mehta, Mr. Amar Dilip Shah and Mr. Pramod Badrinarayan Kasat as Non-Executive Non-Independent Directors of the Company. The Postal Ballot Notice will be dispatched to the Members of the Company in accordance with the applicable provisions of the Companies Act, 2013, the rules made thereunder and the SEBI Listing Regulations. The meeting of the Board of Directors commenced at 6:41 p.m. and concluded at 6:57 p.m. Kindly take the above information on your record and acknowledge. Thanking you, Yours Faithfully, For Bliss GVS Pharma Limited Aditi Bhatt Company Secretary & Compliance Officer Encl.: As above “Annexure – 1” No. Particulars Change 1 Name of the Person Mr. Hetul Krishnakant Mehta 2 Reason for change viz. appointment, Appointment reappointment, resignation, removal, death or otherwise 3 Date of appointment / cessation & September 28, 2026 Term of appointment 4 Brief Profile Mr. Hetul K. Mehta is an entrepreneur with over 30 years of experience in the pharmaceutical industry, particularly in bulk drug manufacturing. He is the Managing Director of Praveen Laboratories Pvt. Ltd., which he co-founded in 1995. He has extensive experience in pharmaceutical manufacturing, regulatory compliance, quality assurance and strategic business management. He has served as an Independent Director of Anupam Rasayan India Limited from 2021 to 2024 and chaired various Board Committees. He is also associated with Globe Envirocare Ltd. and Advanced Diabetes Centre Pvt. Ltd. He has been actively involved with industry bodies including CII and the South Gujarat Chamber of Commerce and Industry. He holds a degree in Chemical Engineering from Bharati Vidyapeeth, Pune. 5 Disclosure of relationships between No relation with any of the directors of the directors Company. 6 Other Confirmation Mr. Hetul Krishnakant Mehta is not debarred or disqualified from being appointed or continuing as a Director of the Company by the SEBI, MCA or any other statutory or regulatory authority order or directions. “Annexure – 2” No. Particulars Change 1 Name of the Person Mr. Amar Dilip Shah 2 Reason for change viz. appointment, Appointment reappointment, resignation, removal, death or otherwise 3 Date of appointment / cessation & September 28, 2026 Term of appointment 4 Brief Profile Mr. Amar Dilip Shah is an experienced business professional with extensive experience in sales, marketing, business development and strategic planning. He is currently associated with Siyaram Silk Mills Limited, where he is responsible for sales across Japan, India and USA and also oversees the P&L of a greenfield garment manufacturing unit. He has significant experience in the apparel and textile industry, including working with high street brands and garment converters. He previously served as Working Director of Futuristic Concepts Media Limited for over 22 years. He has also been associated with Web Werks India Pvt. Ltd., where he handled sales, marketing and business operations. He has expertise in establishing new ventures, operational management, technology implementation and business expansion. He has also undertaken programmes in renewable energy, international energy policy and project management. 5 Disclosure of relationships between No relation with any of the directors of the directors Company. 6 Other Confirmation Mr. Amar Dilip Shah is not debarred or disqualified from being appointed or continuing as a Director of the Company by the SEBI, MCA or any other statutory or regulatory authority order or directions. “Annexure – 3” No. Particulars Change 1 Name of the Person Mr. Pramod Badrinarayan Kasat 2 Reason for change viz. appointment, Appointment reappointment, resignation, removal, death or otherwise 3 Date of appointment / cessat [Showing first 8,000 characters — download PDF for full document]